Prostate Cancer Patients May Benefit from New Fusion Biopsy Systems by UC-Care

Prostate Cancer Patients May Benefit from New Fusion Biopsy Systems by UC-Care
UC-Care and Axella BioVentures announced the introduction of the Navigo and SmartBx Systems, which they believe to offer the most advanced and accurate means of performing a prostate biopsy currently available, into medical practice in the United States. Navigo is a device that helps physicians to plan, place, image, and record prostate biospy samples in high-resolution 3-D. It fuses MRI images that have been previously captured with live transrectal ultrasound (TRUS) when the ultrasound transducer is inserted in the tumor site during the biopsy.
Subscribe or to access all post and page content.